Cytokinetics Inc (CYTK)
66.45
-0.55
(-0.82%)
USD |
NASDAQ |
Apr 19, 13:10
Cytokinetics Cash from Operations (Quarterly): -74.04M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -74.04M |
| September 30, 2023 | -96.20M |
| June 30, 2023 | -121.80M |
| March 31, 2023 | -122.29M |
| December 31, 2022 | -98.19M |
| September 30, 2022 | -84.04M |
| June 30, 2022 | -90.48M |
| March 31, 2022 | -26.81M |
| December 31, 2021 | -44.74M |
| September 30, 2021 | -38.77M |
| June 30, 2021 | -29.50M |
| March 31, 2021 | -29.52M |
| December 31, 2020 | 52.15M |
| September 30, 2020 | 14.37M |
| June 30, 2020 | -27.44M |
| March 31, 2020 | -30.14M |
| December 31, 2019 | -19.06M |
| September 30, 2019 | -20.27M |
| June 30, 2019 | -24.68M |
| March 31, 2019 | -26.91M |
| December 31, 2018 | -12.33M |
| September 30, 2018 | -32.24M |
| June 30, 2018 | -26.85M |
| March 31, 2018 | -29.81M |
| December 31, 2017 | -24.07M |
| Date | Value |
|---|---|
| September 30, 2017 | -25.48M |
| June 30, 2017 | -31.26M |
| March 31, 2017 | -20.94M |
| December 31, 2016 | 77.83M |
| September 30, 2016 | -12.12M |
| June 30, 2016 | -11.22M |
| March 31, 2016 | -17.51M |
| December 31, 2015 | -9.942M |
| September 30, 2015 | -10.35M |
| June 30, 2015 | -9.187M |
| March 31, 2015 | 34.36M |
| December 31, 2014 | -8.13M |
| September 30, 2014 | -9.515M |
| June 30, 2014 | -9.376M |
| March 31, 2014 | -17.82M |
| December 31, 2013 | -12.43M |
| September 30, 2013 | 10.31M |
| June 30, 2013 | 6.624M |
| March 31, 2013 | -12.22M |
| December 31, 2012 | -7.124M |
| September 30, 2012 | -8.878M |
| June 30, 2012 | -8.699M |
| March 31, 2012 | -8.737M |
| December 31, 2011 | -10.94M |
| September 30, 2011 | -9.264M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-122.29M
Minimum
Mar 2023
52.15M
Maximum
Dec 2020
-47.97M
Average
-30.14M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 538.00M |
| Johnson & Johnson | 7.863B |
| Eli Lilly and Co | -311.90M |
| Viking Therapeutics Inc | -17.64M |
| Madrigal Pharmaceuticals Inc | -79.93M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -81.41M |
| Cash from Financing (Quarterly) | 168.80M |
| Free Cash Flow | -415.75M |
| Free Cash Flow Per Share (Quarterly) | -0.7479 |
| Free Cash Flow to Equity (Quarterly) | -82.55M |
| Free Cash Flow Yield | -6.48% |